Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-26T18:46:43.096Z Has data issue: false hasContentIssue false

Chapter 19 - Lung Cancer

Published online by Cambridge University Press:  23 October 2024

By
Maria Azhar ,
Lara Bashoura  and
Saadia A. Faiz
Edited by
Laurie J. Mckenzie  and
Denise R. Nebgen
Laurie J. Mckenzie
Affiliation:
University of Texas MD Anderson Cancer Center, Houston
Denise R. Nebgen
Affiliation:
University of Texas MD Anderson Cancer Center, Houston
Get access

Summary

Lung cancer has emerged as a distinct disease in women, and women have unique risk factors as compared to men. Women are more likely to be diagnosed at a young age with adenocarcinoma, lack a significant smoking history and carry driver mutations. Current screening guidelines center around tobacco use, so health care disparities related to gender may impact those women who never smoked and/or prone to lung cancer from distinct etiologies. Molecular and immune markers are important in the workup for cancer, and new treatments with targeted and immune-mediated therapies are available. Women diagnosed with lung cancer have improved survival rates compared to men even while accounting for stage of diagnosis, age, smoking history and treatment modality. Lung cancer survivorship issues can contribute to significant symptom burden, and these can include cancer-related fatigue, reproductive issues, sexual health and sleep disruption. The impact of lung cancer and its’ therapies can affect quality of life especially when treatment-related complications are persistent.

Keywords

lung cancerwomenhealth care disparitiestreatment-related complicationsadenocarcinomacancer-related fatigue
Type
Chapter
Information
Caring for the Female Cancer Patient
Gynecologic Considerations
 , pp. 331 - 345
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Thai, A. A., Solomon, B. J., Sequist, L. V., Gainor, J. F., Heist, R. S. Lung cancer. Lancet. 2021;398(10299):535–54.CrossRefGoogle ScholarPubMed
MacRosty, C. R., Rivera, M. P. Lung cancer in women: A modern epidemic. Clin Chest Med. 2020;41(1):53–65.CrossRefGoogle ScholarPubMed
Kligerman, S., White, C. Epidemiology of lung cancer in women: Risk factors, survival, and screening. AJR Am J Roentgenol. 2011;196(2):287–95.CrossRefGoogle ScholarPubMed
Tanoue, L. T. Women and lung cancer. Clin Chest Med. 2021;42(3):467–82.CrossRefGoogle ScholarPubMed
Sung, H., Ferlay, J., Siegel, R. L., et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancer in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefGoogle ScholarPubMed
Sun, S., Schiller, J. H., Gazdar, A. F. Lung cancer in never smokers: A different disease. Nat Rev Cancer. 2007;7(10):778–90.CrossRefGoogle ScholarPubMed
Jemal, A., Miller, K. D., Ma, J., et al. Higher lung cancer incidence in young women than young men in the United States. N Engl J Med. 2018;378(21):1999–2009.CrossRefGoogle ScholarPubMed
Fu, J. B., Kau, T. Y., Severson, R. K., Kalemkerian, G. P. Lung cancer in women: Analysis of the national Surveillance, Epidemiology, and End Results database. Chest. 2005;127(3):768–77.CrossRefGoogle ScholarPubMed
Ragavan, M., Patel, M. I. The evolving landscape of sex-based differences in lung cancer: A distinct disease in women. Eur Respir Rev. 2022;31(163):210100.CrossRefGoogle ScholarPubMed
Thun, M. J., Carter, B. D., Feskanich, D., et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med. 2013;368(4):351–64.CrossRefGoogle ScholarPubMed
Novello, S., Vavala, T. Lung cancer and women. Future Oncol. 2008;4(5):705–16.CrossRefGoogle ScholarPubMed
Slatore, C. G., Chien, J. W., Au, D. H., Satia, J. A., White, E. Lung cancer and hormone replacement therapy: Association in the vitamins and lifestyle study. J Clin Oncol. 2010;28(9):1540–6.CrossRefGoogle ScholarPubMed
Chlebowski, R. T., Schwartz, A. G., Wakelee, H., et al. Oestrogen plus progestin and lung cancer in postmenopausal women (Women’s Health Initiative trial): A post-hoc analysis of a randomised controlled trial. Lancet. 2009;374(9697):1243–51.CrossRefGoogle Scholar
Heiss, G., Wallace, R., Anderson, G. L., et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA. 2008;299(9):1036–45.CrossRefGoogle ScholarPubMed
Yin, X., Zhu, Z., Hosgood, H. D., Lan, Q., Seow, W. J. Reproductive factors and lung cancer risk: A comprehensive systematic review and meta-analysis. BMC Public Health. 2020;20(1):1458.CrossRefGoogle Scholar
Fei, Y., Yang, J., Hsieh, W. C., et al. Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China. Jpn J Clin Oncol. 2006;36(5):274–9.CrossRefGoogle ScholarPubMed
Cheng, Y. W., Chiou, H. L., Sheu, G. T., et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res. 2001;61(7):2799–803.Google ScholarPubMed
Kaufman, E. L., Jacobson, J. S., Hershman, D. L., Desai, M., Neugut, A. I. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol. 2008;26(3):392–8.CrossRefGoogle ScholarPubMed
Travis, L. B., Gospodarowicz, M., Curtis, R. E., et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin’s disease. J Natl Cancer Inst. 2002;94(3):182–92.CrossRefGoogle ScholarPubMed
Force, USPST, Krist, A. H., Davidson, K. W., et al. Screening for lung cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(10):962–70.Google Scholar
Pinsky, P. F., Lau, Y. K., Doubeni, C. A. Potential disparities by sex and race or ethnicity in lung cancer screening eligibility rates. Chest. 2021;160(1):341–50.CrossRefGoogle ScholarPubMed
Kocher, F., Hilbe, W., Seeber, A., Pircher, , et al. Longitudinal analysis of 2293 NSCLC patients: A comprehensive study from the TYROL registry. Lung Cancer. 2015;87(2):193–200.CrossRefGoogle ScholarPubMed
Kalemkerian, G. P., Narula, N., Kennedy, E. B., et al. Molecular testing guideline for the selection of patients with lung cancer for treatment with targeted tyrosine kinase inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update. J Clin Oncol. 2018;36(9):911–19.CrossRefGoogle Scholar
Lindeman, N. I., Cagle, P. T., Aisner, D. L., et al. Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: Guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. J Thorac Oncol. 2018;13(3):323–58.CrossRefGoogle Scholar
Lynch, T. J., Bell, D. W., Sordella, R., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;350(21):2129–39.CrossRefGoogle ScholarPubMed
Detterbeck, F. C., Boffa, D. J., Kim, A. W., Tanoue, L. T. The Eighth Edition Lung Cancer Stage Classification. Chest. 2017;151(1):193–203.CrossRefGoogle ScholarPubMed
Sagerup, C. M., Smastuen, M., Johannesen, T. B., Helland, A., Brustugun, O. T. Sex-specific trends in lung cancer incidence and survival: A population study of 40,118 cases. Thorax. 2011;66(4):301–7.CrossRefGoogle ScholarPubMed
Nakamura, H., Ando, K., Shinmyo, T., et al. Female gender is an independent prognostic factor in non-small-cell lung cancer: A meta-analysis. Ann Thorac Cardiovasc Surg. 2011;17(5):469–80.CrossRefGoogle ScholarPubMed
Husain, Z. A., Kim, A. W., Yu, J. B., Decker, R. H., Corso, C. D. Defining the high-risk population for mortality after resection of early stage NSCLC. Clin Lung Cancer. 2015;16(6):e183–7.CrossRefGoogle ScholarPubMed
Chang, M. Y., Mentzer, S. J., Colson, Y. L., et al. Factors predicting poor survival after resection of stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2007;134(4):850–6.CrossRefGoogle ScholarPubMed
Reck, M., Rodriguez-Abreu, D., Robinson, A. G., et al. Pembrolizumab versus chemotherapy for PD-L1-Positive non-small-cell lung cancer. N Engl J Med. 2016;375(19):1823–33.CrossRefGoogle ScholarPubMed
Mascaux, C., Iannino, N., Martin, B., et al. The role of RAS oncogene in survival of patients with lung cancer: A systematic review of the literature with meta-analysis. Br J Cancer. 2005;92(1):131–9.CrossRefGoogle ScholarPubMed
Alexiou, C., Onyeaka, C. V., Beggs, D., et al. Do women live longer following lung resection for carcinoma? Eur J Cardiothorac Surg. 2002;21(2):319–25.CrossRefGoogle ScholarPubMed
Ferguson, M. K., Wang, J., Hoffman, P. C., et al. Sex-associated differences in survival of patients undergoing resection for lung cancer. Ann Thorac Surg. 2000;69(1):245–9; discussion 249–50.CrossRefGoogle ScholarPubMed
Yoshino, I., Baba, H., Fukuyama, S., et al. A time trend of profile and surgical results in 1123 patients with non-small cell lung cancer. Surgery. 2002;131(1 Suppl):S242–8.CrossRefGoogle ScholarPubMed
Yang, C. J., Kumar, A., Klapper, J. A., et al. A national analysis of long-term survival following thoracoscopic versus open lobectomy for stage I non-small-cell lung cancer. Ann Surg. 2019;269(1):163–71.CrossRefGoogle ScholarPubMed
Bendixen, M., Jorgensen, O. D., Kronborg, C., Andersen, C., Licht, P. B. Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: A randomised controlled trial. Lancet Oncol. 2016;17(6):836–44.CrossRefGoogle ScholarPubMed
Timmerman, R., Paulus, R., Galvin, J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070–6.Google ScholarPubMed
Kozower, B. D., Larner, J. M., Detterbeck, F. C., Jones, D. R. Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e369S–e99S.CrossRefGoogle ScholarPubMed
Eichhorn, F., Winter, H. How to handle oligometastatic disease in nonsmall cell lung cancer. Eur Respir Rev. 2021;30(159):200234.CrossRefGoogle ScholarPubMed
Pozo, C. L., Morgan, M. A., Gray, J. E. Survivorship issues for patients with lung cancer. Cancer Control. 2014;21(1):40–50.CrossRefGoogle ScholarPubMed
Bower, J. E. Cancer-related fatigue: Mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014;11(10):597–609.CrossRefGoogle ScholarPubMed
Bade, B. C., Faiz, S. A., Ha, D. M., et al. Cancer-related fatigue in lung cancer: A research agenda: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2023;207(5):e6–e28.CrossRefGoogle ScholarPubMed
Loren, A. W., Mangu, P. B., Beck, L. N., et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500–10.CrossRefGoogle ScholarPubMed
Bellido, C., Barbero, P., Forcen, L., et al. Lung adenocarcinoma during pregnancy: Clinical case and literature review. J Matern Fetal Neonatal Med. 2019;32(19):3300–2.CrossRefGoogle ScholarPubMed
Rothschild, S. I. Lung cancer in pregnancy: A forgotten disease entity. J Thorac Oncol. 2016;11(9):1376–8.CrossRefGoogle ScholarPubMed
Dagogo-Jack, I., Gainor, J. F., Porter, R. L., et al. Clinicopathologic features of NSCLC diagnosed during pregnancy or the peripartum period in the era of molecular genotyping. J Thorac Oncol. 2016;11(9):1522–8.CrossRefGoogle ScholarPubMed
Rabinowitz, M. J., Kohn, T. P., Pena, V. N., et al. Onset of azoospermia in man treated with ipilimumab/nivolumab for BRAF negative metastatic melanoma. Urol Case Rep. 2021;34:101488.CrossRefGoogle ScholarPubMed
de Filette, J., Andreescu, C. E., Cools, F., Bravenboer, B., Velkeniers, B. A systematic review and meta-analysis of endocrine-related adverse events associated with immune checkpoint inhibitors. Horm Metab Res. 2019;51(3):145–56.Google ScholarPubMed
Del Pup, L., Villa, P., Amar, I. D., Bottoni, C., Scambia, G. Approach to sexual dysfunction in women with cancer. Int J Gynecol Cancer. 2019;29(3):630–4.CrossRefGoogle ScholarPubMed
Reese, J. B., Shelby, R. A., Abernethy, A. P. Sexual concerns in lung cancer patients: An examination of predictors and moderating effects of age and gender. Support Care Cancer. 2011;19(1):161–5.CrossRefGoogle ScholarPubMed
Davidson, J. R., MacLean, A. W., Brundage, M. D., Schulze, K. Sleep disturbance in cancer patients. Soc Sci Med. 2002;54(9):1309–21.CrossRefGoogle ScholarPubMed
Silberfarb, P. M., Hauri, P. J., Oxman, T. E., Schnurr, P. Assessment of sleep in patients with lung cancer and breast cancer. J Clin Oncol. 1993;11(5):997–1004.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×